Myrexis (MYRX) Announces Publication of Phase 2b Azixa Data

February 3, 2011 9:12 AM EST Send to a Friend
Myrexis, Inc. (Nasdaq: MYRX) announces publication of Azixa (MPC-6827, verubulin) data.

Azixa is the Company's lead compound currently under ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login